The Bioseparation Systems Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
New York, NY -- (SBWIRE) -- 05/12/2017 -- Bioseparation systems are used for the separation and purification of biological products such as biochemicals, biopharmaceuticals, and diagnostic reagents. Several types of bioseparation systems are used to separate biological materials from solutions, with the most commonly-used ones being: Membrane/filters, chromatography and centrifuges.
Membranes are a thin semi-permeable barrier that separates biological materials. A membrane is usually made from organic polymers or inorganic materials such as metals, ceramics and glass. Chromatography is a solute fractionation technique which relies on the distribution of molecules to be separated between two phases: Stationary phase and mobile phase. The centrifugation technique is used to separate biological particles from suspensions and macromolecules from solutions.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/4735
The global bioseparation systems market is categorized based on various types of bioseparation technologies and their applications. Based on bioseparation technologies, the report covers the following: Chromatography technique, membrane-based bioseparation, centrifugation technology, cell disruption technology, precipitation, extraction technique, and filtration technologies. The chromatography technique holds the largest market share in the global bioseparation systems market.
Based on applications of bioseparation systems, the report covers the following industries: Pharmaceutical and biopharmaceutical, life sciences, and food. Bioseparation systems are most frequently used in the pharmaceutical and biopharmaceutical industries.
Geographically, North America dominates the global bioseparation systems market. This is due to the improved life sciences research infrastructure and increasing demand for biopharmaceuticals in the region. In addition, technological advancements in equipment used in bioseparation procedures have also propelled the growth of the market in North America. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada.
In Europe, Germany, France, and the U.K. hold major shares of the bioseparation systems market. The bioseparation systems market in Asia too, is expected to show high growth rates over the next five years. This can be credited to the increasing demand for biopharmaceuticals in the region. In addition, many biopharmaceutical manufacturing companies are planning to construct their production units in Asian countries attracted by the less stringent regulations and low labor cost in the region. Growing population and economies of developing countries such as India and China are expected to steer the growth of the bioseparation systems market in Asia. Moreover, India, China, and Japan, are expected to be the fastest-growing markets for bioseparation systems in the region.
Increasing demand for biopharmaceuticals and single-use products are some major driving factors for the global bioseparation systems market. Also, technological advancements in equipment used in bioseparation and various initiatives taken by government organizations to increase awareness about therapeutic applications of biosimilars have propelled the growth of the global bioseparation systems market.
Stringent regulatory requirements for the approval of equipment used in bioseparation inhibit the growth of global bioseparation systems market. Rapid product launches and heightened mergers and acquisitions between medical device manufacturing companies are major trends observed in the global bioseparation systems market.
To view TOC of this report is available upon request @ http://www.persistencemarketresearch.com/toc/4735
Top companies profiled in this report are:
GE Healthcare Life Sciences, Merck Millipore, Pall Corporation, Sartorius AG, 3M Company, Agilent Technologies, Waters Corporation, US Filter Control Systems, Inc., Asahi Kasei Corporation, Bio-Rad Laboratories, Inc., Dow Chemical Company, Hitachi Koki Co LTD, Life Technologies, NOVASEP, ProMetic Life Sciences Inc., SPECTRUM LABORATORIES, INC, NuSep Inc.